Hyponatremia Clinical Trial
Official title:
Phenotypic Characterization of Neuropsychologic and Physical Performance in Geriatric Patients Suffering From Hyponatremia.
Our purpose is to investigate the improvement of the cognitive, neuropsychologic and physical capabilities using a standardized multidimensional geriatric assessment (MGA) consisting of a battery of validated assays after correction of hyponatremia in patients 70 years or older.
With an occurrence of up to 30%, hyponatremia, defined as a serum sodium concentration of
less than 135 mmol/L, is the most commonly encountered electrolyte disorder in hospitalized
patients today. The highest incidence of hyponatremia is found in the elderly.
Retrospective analyses clearly show an association between hyponatremia and mortality as well
as morbidity and this association is not confined only to severely decreased sodium levels.
Hyponatremia can be an acute and life-threatening condition, which is usually reflected by
severe signs and symptoms, e.g. coma or seizures,but more often it is of chronic nature, and
symptoms may be subtle or even apparently absent due to cerebral adaptation processes. Signs
and symptoms include, among others, nausea, drowsiness, cognitive impairment, memory
deficits, depression, muscle cramps, or gait instability. However, our knowledge of the
highly diverse clinical picture of hyponatremia stems from anecdotic reports and experiments
that were performed by the investigators on themselves in the 1930ies. Thus, no accurate and
thorough description of the symptomatology of hyponatremiain disease has been carried out so
far, except maybe for the extreme conditions, i.e. in patients suffering from seizures or
coma. This is why especially patients with chronic mild-to-moderate hyponatremia (sometimes
defined as a sodium concentration > 125 mmol/L) who may well have subtle or unspecific
symptoms are often perceived as being asymptomatic. Recent investigations have demonstrated
that such patients have a significantly increased risk for falls and bone fractures and
reduced cognitive capacities. Moreover, anecdotic reports have shown that some patients that
were believed to suffer from depression or dementia improved markedly after correction of
their concomitanthyponatremia. There is also mounting evidence that hyponatremia induces
osteoporosis which adds to the risk of bone fractures. Furthermore, in the SALT-trials, the
mental component of the SF-12 questionnaire (Short Form-12) improved significantly after
hyponatremia had been corrected. Interestingly, the mean sodium concentration prior to
treatment was 129 mmol/L indicating mild or moderate hyponatremia. Given the high prevalence
of mild-to-moderate hyponatremiain the elderly, unspecific symptoms like mood instability,
cognitive deficits or others, thatare often attributed to old age could simply be a
consequence of their low sodium level.
To this end, it might well be that by treating hyponatremia the morbidity/mortality in this
population could be reduced and quality of life improved. In light of the growing
medico-economic challenges we are facing secondary to the steadily increasing life expectancy
and the demographic evolution in the western world and the medical problems that come along
with this development the influence of successful correction of hyponatremia on mental and
physical health should be evaluated. To our knowledge this has not been investigated so far.
The syndrome of inappropriate ADH secretion (SIADH) accounts for more than a third of all
cases of hyponatremia and probably is by far the most frequent aetiology of chronic mild to
moderate hyponatremia. While newly developed SIADH is often induced by malignancies,
pulmonary or cerebral disease in the general population, longstanding chronic hyponatremia in
elderly is usually due to idiopathic or drug-associated SIADH. Apart from SIADH, hypovolemia
or reduction of the effective arterial blood volume, e.g. in cardiac failure or liver
cirrhosis, are common causes of hyponatremia. Although hyponatremia might have an impact on
the mental and physical status as well as on the patient's prognosis regardless of the
underlying cause, most aetiologies except for SIADH might be confounding factors, since they
often induce a "hyponatremia-like" clinical picture by themselves, e.g. hepatic
encephalopathy in liver disease etc. Another possible confounder may be hemoglobin. Recent
work shows that hyponatremia is associated with anaemia, which is a highly prevalent symptom
in elderly patients and an acknowledged risk factor for poor outcome in this population. The
underlying pathogenesis of this association is still unknown. Regarding the fact that anaemia
and hyponatremia are both risk factors for increased morbidity and mortality in elderly
patients that are potentially curable, analysis of influence on the multidimensional
geriatric assessment (MGA) before and after correction is challenging. To our knowledge,
these possible confounders have not been accounted for in the existing literature. Moreover,
no accurate evaluation of the origin of hyponatremia has been reported.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06037928 -
Plasma Sodium and Sodium Administration in the ICU
|
||
Recruiting |
NCT04561531 -
Efficacy and Safety of Bolus Comparing With Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyponatremia.
|
N/A | |
Terminated |
NCT02012959 -
Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
|
Phase 3 | |
Recruiting |
NCT02936167 -
Comparison of Ringer Lactate and Isotonic Acetate Solution as Perioperative Maintenance Fluid for Children
|
N/A | |
Completed |
NCT00621348 -
Maintenance Intravenous Fluids in Children
|
Phase 3 | |
Terminated |
NCT03703713 -
Colloid Osmotic Pressure and Osmolality in Hyponatremia
|
||
Completed |
NCT02926989 -
Intravenous Fluids in Hospitalised Children
|
Phase 4 | |
Terminated |
NCT02959411 -
Tolvaptan for Advanced or Refractory Heart Failure
|
Phase 4 | |
Completed |
NCT02573077 -
An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy
|
||
Withdrawn |
NCT02667977 -
Reexamining Hypotonic Intravenous Fluid Use
|
N/A | |
Terminated |
NCT01708811 -
Hyponatremia and Myometrium Contractility. An Invitro Study
|
N/A | |
Completed |
NCT01456533 -
Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients
|
N/A | |
Withdrawn |
NCT01326429 -
Frequency and Origin of Dysnatremias in the Emergency Department
|
N/A | |
Terminated |
NCT01227512 -
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
|
Phase 3 | |
Recruiting |
NCT06013800 -
Hyponatremia Volume Status Analysis by Point-of-care Ultrasound
|
||
Terminated |
NCT04020926 -
Impact of Hyponatremia on Muscle Strength, Gait and Cognitive Function
|
||
Completed |
NCT02545101 -
An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH
|
N/A | |
Withdrawn |
NCT02442674 -
A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
|
Phase 3 | |
Terminated |
NCT02215148 -
Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients
|
N/A | |
Recruiting |
NCT01748331 -
The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia
|
N/A |